Brief: Hofseth Biocare Q1 Revenue at NOK 44 Million
12/05/2023 06:57
May 12 (Reuters) - Hofseth Biocare Q1 adjusted free cash flow NOK 100 thousand. * Q1 revenue NOK 44 million * Q1 adjusted EBITDA NOK -19.8 million
Recent news on Hofseth Biocare ASA
See all newsBrief: Hofseth BioCare Board Member Buys 2.5 Mln Shares in Company
Brief: Hofseth Biocare Appoints Leif Arne Giske As CFO
Hofseth BioCare Q2 operating revenue slips on lower raw material volumes
Brief: Hofseth Biocare Q2 Revenue NOK 65.7 Million
Brief: Research Corporation Buys 14.3 Mln Shares In Hofseth Biocare